• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病合并难治性高血压。

Resistant hypertension in diabetes mellitus.

机构信息

Division of Kidney Diseases and Hypertension, Rhode Island Hospital, APC 9, 593 Eddy St., Providence, RI, 02906, USA,

出版信息

Curr Diab Rep. 2014 Aug;14(8):516. doi: 10.1007/s11892-014-0516-y.

DOI:10.1007/s11892-014-0516-y
PMID:24965963
Abstract

Resistant hypertension in diabetes is associated with poor cardiovascular and renal outcomes. This brief review will examine the definitions and epidemiology of resistant hypertension and consider the differences between apparent resistant hypertension and truly resistant or refractory hypertension. It will review the role of the sympathetic nervous system in resistant hypertension. It will consider the relationship between obesity and leptin resistance and sympathetic signaling; the role of obstructive sleep apnea in resistant hypertension; and the role of aldosterone in resistant hypertension. It will conclude by mentioning briefly renal nerve ablation.

摘要

糖尿病患者的高血压耐药与心血管和肾脏不良结局相关。这篇简要综述将探讨高血压耐药的定义和流行病学,并考虑表观性高血压耐药和真正的耐药或难治性高血压之间的区别。文中将回顾交感神经系统在高血压耐药中的作用,讨论肥胖和瘦素抵抗与交感信号之间的关系、阻塞性睡眠呼吸暂停在高血压耐药中的作用,以及醛固酮在高血压耐药中的作用。最后将简要提及肾神经消融术。

相似文献

1
Resistant hypertension in diabetes mellitus.糖尿病合并难治性高血压。
Curr Diab Rep. 2014 Aug;14(8):516. doi: 10.1007/s11892-014-0516-y.
2
Obesity, sleep apnea, aldosterone, and hypertension.肥胖、睡眠呼吸暂停、醛固酮与高血压。
Curr Hypertens Rep. 2008 Jun;10(3):222-6. doi: 10.1007/s11906-008-0042-x.
3
Obesity, kidney dysfunction and hypertension: mechanistic links.肥胖、肾功能障碍和高血压:机制联系。
Nat Rev Nephrol. 2019 Jun;15(6):367-385. doi: 10.1038/s41581-019-0145-4.
4
Sex differences in sympathetic activity in obesity and its related hypertension.肥胖及其相关高血压患者交感神经活性的性别差异。
Ann N Y Acad Sci. 2019 Oct;1454(1):31-41. doi: 10.1111/nyas.14095. Epub 2019 May 14.
5
Hypertension in obesity and NIDDM. Role of insulin and sympathetic nervous system.肥胖与非胰岛素依赖型糖尿病中的高血压。胰岛素和交感神经系统的作用。
Diabetes Care. 1991 Mar;14(3):240-8. doi: 10.2337/diacare.14.3.240.
6
Cardiovascular and renal complications of type 2 diabetes in obesity: role of sympathetic nerve activity and insulin resistance.肥胖症中2型糖尿病的心血管和肾脏并发症:交感神经活动及胰岛素抵抗的作用
Curr Diabetes Rev. 2010 Mar;6(2):58-67. doi: 10.2174/157339910790909396.
7
Neural mechanisms and management of obesity-related hypertension.肥胖相关高血压的神经机制与管理
Curr Cardiol Rep. 2008 Nov;10(6):456-63. doi: 10.1007/s11886-008-0072-7.
8
Leptin and aldosterone in sympathetic activity in resistant hypertension with or without type 2 diabetes.瘦素和醛固酮在伴或不伴 2 型糖尿病的抵抗性高血压中的交感神经活性作用。
Arq Bras Cardiol. 2012 Jul;99(1):642-8. doi: 10.1590/s0066-782x2012005000047. Epub 2012 May 29.
9
Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.肥胖相关性高血压中的交感神经系统:机制与临床意义。
Hypertens Res. 2012 Jan;35(1):4-16. doi: 10.1038/hr.2011.173. Epub 2011 Nov 3.
10
Sympathetic nervous system and insulin resistance: from obesity to diabetes.交感神经系统与胰岛素抵抗:从肥胖到糖尿病
Am J Hypertens. 2001 Nov;14(11 Pt 2):304S-309S. doi: 10.1016/s0895-7061(01)02236-1.

引用本文的文献

1
Empagliflozin for Patients With Presumed Resistant Hypertension: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.恩格列净治疗疑似耐药性高血压患者:来自 EMPA-REG OUTCOME 试验的事后分析。
Am J Hypertens. 2020 Dec 31;33(12):1092-1101. doi: 10.1093/ajh/hpaa073.

本文引用的文献

1
A controlled trial of renal denervation for resistant hypertension.经导管射频消融去肾交感神经术治疗高血压的对照试验
N Engl J Med. 2014 Apr 10;370(15):1393-401. doi: 10.1056/NEJMoa1402670. Epub 2014 Mar 29.
2
Leptin enhances insulin sensitivity by direct and sympathetic nervous system regulation of muscle IGFBP-2 expression: evidence from nonrodent models.瘦素通过直接和交感神经系统调节肌肉 IGFBP-2 表达增强胰岛素敏感性:来自非啮齿动物模型的证据。
Endocrinology. 2014 Jun;155(6):2133-43. doi: 10.1210/en.2013-2099. Epub 2014 Mar 21.
3
Blunted sympathoinhibitory responses in obesity-related hypertension are due to aberrant central but not peripheral signalling mechanisms.
肥胖相关性高血压中交感抑制反应迟钝的原因是中枢而非外周信号机制异常。
J Physiol. 2014 Apr 1;592(7):1705-20. doi: 10.1113/jphysiol.2013.269670. Epub 2014 Feb 3.
4
Sympathetic nervous system moves toward center stage in cardiovascular medicine: from Thomas Willis to resistant hypertension.交感神经系统在心血管医学中走向核心地位:从托马斯·威利斯到顽固性高血压
Hypertension. 2014 Mar;63(3):e25-32. doi: 10.1161/HYPERTENSIONAHA.113.02439. Epub 2014 Jan 13.
5
Deregulation of adipokines related to target organ damage on resistant hypertension.与难治性高血压靶器官损伤相关的脂肪因子失调
J Hum Hypertens. 2014 Jun;28(6):388-92. doi: 10.1038/jhh.2013.118. Epub 2013 Nov 28.
6
Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.动态阻力性高血压模式对心血管发病率的预测作用:一项为期 4 年的前瞻性研究。
J Hypertens. 2014 Feb;32(2):415-22. doi: 10.1097/HJH.0000000000000023.
7
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.经皮肾动脉去神经术治疗抗高血压药物抵抗的高血压患者:Symplicity HTN-1 研究的最终 3 年报告。
Lancet. 2014 Feb 15;383(9917):622-9. doi: 10.1016/S0140-6736(13)62192-3. Epub 2013 Nov 7.
8
Low rate of resistant hypertension in Chinese patients with hypertension: an analysis of the HOT-CHINA study.中国高血压患者中难治性高血压的低发生率:HOT-CHINA研究分析
J Hypertens. 2013 Dec;31(12):2386-90. doi: 10.1097/HJH.0b013e32836586a1.
9
Antihypertensive treatment and resistant hypertension in patients with type 1 diabetes by stages of diabetic nephropathy.1 型糖尿病患者按糖尿病肾病分期的降压治疗及难治性高血压。
Diabetes Care. 2014;37(3):709-17. doi: 10.2337/dc13-2023. Epub 2013 Oct 29.
10
Low dose spironolactone reduces blood pressure in patients with resistant hypertension and type 2 diabetes mellitus: a double blind randomized clinical trial.低剂量螺内酯可降低耐药性高血压合并 2 型糖尿病患者的血压:一项双盲随机临床试验。
J Hypertens. 2013 Oct;31(10):2094-102. doi: 10.1097/HJH.0b013e3283638b1a.